GB1570494A
(en)
*
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
GB8912335D0
(en)
*
|
1989-05-30 |
1989-07-12 |
Smithkline Beckman Intercredit |
Compounds
|
US5280026A
(en)
*
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
US5098902A
(en)
*
|
1991-03-18 |
1992-03-24 |
Warner-Lambert Company |
Method of treating neurodegenerative diseases
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
US6608053B2
(en)
*
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
EP2060575A1
(de)
*
|
2006-04-19 |
2009-05-20 |
Boehringer Ingelheim International GmbH |
Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
|
EP1847543A1
(de)
|
2006-04-19 |
2007-10-24 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
|
TW200801012A
(en)
|
2006-04-26 |
2008-01-01 |
Piramed Ltd |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
ES2347187T3
(es)
|
2006-04-26 |
2010-10-26 |
F. Hoffmann-La Roche Ag |
Derivado de tieno(3,2-d)pirimidina, util como un inhibidor de pi3k.
|
ATE532788T1
(de)
*
|
2006-04-26 |
2011-11-15 |
Hoffmann La Roche |
Pharmazeutische verbindungen
|
AR064154A1
(es)
*
|
2006-12-07 |
2009-03-18 |
Piramed Ltd |
Compuestos inhibidores de fodfoinostida 3- quinasas y composiciones farmaceuticas
|
ES2544082T3
(es)
|
2006-12-07 |
2015-08-27 |
F. Hoffmann-La Roche Ag |
Compuestos inhibidores de fosfoinosítido 3-quinasa y métodos de uso
|
WO2009042607A1
(en)
|
2007-09-24 |
2009-04-02 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
DK2610258T3
(da)
*
|
2007-10-19 |
2014-11-10 |
Boehringer Ingelheim Int |
Substituerede piperidindihydrothienopyrimidiner
|
RU2500681C2
(ru)
*
|
2007-10-19 |
2013-12-10 |
Берингер Ингельхайм Интернациональ Гмбх |
Замещенные гетероциклом пиперазинодигидротиенопиримидины
|
JP5563466B2
(ja)
|
2007-10-19 |
2014-07-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ピペラジノ−ジヒドロチエノピリミジン誘導体
|
JP5348725B2
(ja)
|
2007-10-25 |
2013-11-20 |
ジェネンテック, インコーポレイテッド |
チエノピリミジン化合物の製造方法
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
BRPI1006189A2
(pt)
|
2009-03-12 |
2020-08-18 |
Genentech Inc |
uso de uma combinação terapêutica, formulação farmacêutica, artigo de manufatura, produto, método para determinar compostos a serem utilizados em combinação para o tratamento de uma malignidade hematopoiética e método para selecionar compostos a serem utilizados em combinação para o tratamento de câncer
|
WO2010138589A1
(en)
|
2009-05-27 |
2010-12-02 |
Genentech, Inc. |
Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
SG182247A1
(en)
*
|
2009-05-27 |
2012-08-30 |
Hoffmann La Roche |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
RU2563193C2
(ru)
*
|
2009-10-12 |
2015-09-20 |
Ф.Хоффманн-Ля Рош Аг |
Комбинации ингибитора pi3k и ингибитора мек
|
CN103038643A
(zh)
|
2010-04-16 |
2013-04-10 |
基因泰克公司 |
作为pi3k/akt激酶途径抑制剂效能的预测性生物标记的foxo3a
|
US20140004209A1
(en)
|
2010-12-22 |
2014-01-02 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
US20130059866A1
(en)
|
2011-08-24 |
2013-03-07 |
Boehringer Ingelheim International Gmbh |
Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
|
US9802954B2
(en)
|
2011-08-24 |
2017-10-31 |
Boehringer Ingelheim International Gmbh |
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
|
KR102182488B1
(ko)
|
2013-02-25 |
2020-11-24 |
제넨테크, 인크. |
약물 내성 akt 돌연변이체의 검출 및 치료를 위한 방법 및 조성물
|
IL281811B2
(en)
*
|
2018-10-01 |
2025-03-01 |
Genzyme Corp |
Thieno[3,2-B]pyridine derivatives as UPD glycosyltransferase inhibitors and methods of use
|
GB202014736D0
(en)
*
|
2020-09-18 |
2020-11-04 |
Imperial College Innovations Ltd |
Novel compounds and their use in therapy
|